Dendritic cells (DCs) are essential components of innate immunity against Leishmania infection. The mechanisms underlying the complex interaction between DCs and Leishmania remain poorly understood. Here, we describe methods to evaluate how Leishmania infection affects the immunobiological function of human DCs, such as migration-related and costimulatory molecule expression.
Leishmaniasis comprises a collection of clinical manifestations associated with the infection of obligate intracellular protozoans, Leishmania. The life cycle of Leishmania parasites consists of two alternating life stages (amastigotes and promastigotes), during which parasites reside within either arthropod vectors or vertebrate hosts, respectively. Notably, the complex interactions between Leishmania parasites and several cells of the immune system largely influence the outcome of infection. Importantly, although macrophages are known to be the main host niche for Leishmania replication, parasites are also phagocytosed by other innate immune cells, such as neutrophils and dendritic cells (DCs).
DCs play a major role in bridging the innate and adaptive branches of immunity and thus orchestrate immune responses against a wide range of pathogens. The mechanisms by which Leishmania and DCs interact remain unclear and involve aspects of pathogen capture, the dynamics of DC maturation and activation, DC migration to draining lymph node (dLNs), and antigen presentation to T cells. Although a large body of studies support the notion that DCs play a dual role in modulating immune responses against Leishmania, the participation of these cells in susceptibility or resistance to Leishmania remains poorly understood. After infection, DCs undergo a maturation process associated with the upregulation of surface major histocompatibility complex (MHC) II, in addition to costimulatory molecules (namely, CD40, CD80, and CD86).
Understanding the role of DCs in infection outcome is crucial to developing therapeutic and prophylactic strategies to modulate the immune response against Leishmania. This paper describes a method for the characterization of Leishmania-DC interaction. This detailed protocol provides guidance throughout the steps of DC differentiation, the characterization of cell surface molecules, and infection protocols, allowing scientists to investigate DC response to Leishmania infection and gain insight into the roles played by these cells in the course of infection.
Leishmaniasis constitutes a complex of neglected diseases caused by different species of the Leishmania genus1. Leishmania is an intracellular protozoan of the Trypanosomatidae family that infects humans and other mammals, causing a spectrum of diseases ranging from skin lesions to visceral forms2. The main clinical manifestations of this disease are tegumentary leishmaniasis (TL) and visceral leishmaniasis (VL). The World Health Organization (WHO) estimates that 700,000 to 1 million new cases occur annually, causing 70,000 deaths each year2. Worldwide, leishmaniasis affects approximately 12 to 15 million people, and 350 million are at risk of contracting the disease3.
The genus Leishmania presents two evolutionary forms: the promastigote and the amastigote4. Leishmania promastigotes are characterized by the presence of flagella and high motility. These forms are found in the digestive tract of the sand fly, where they undergo differentiation into the infective form (metacyclic promastigotes)5. By contrast, amastigotes are found in the intracellular environment of infected mammalian cells. This evolutionary form, in turn, replicates in the phagolysosomes of phagocytic cells6.
The transmission cycle of Leishmania spp. starts during blood-feeding, when sandflies inoculate metacyclic promastigotes into the host's skin1. Shortly after Leishmania inoculation, innate immune cells, including neutrophils and tissue-resident macrophages, phagocytize the parasites. Inside parasitophorous vacuoles, Leishmania differentiate into amastigotes and replicate, culminating in the rupture of the host cell membrane, which allows the infection of neighboring cells and parasite spread4. The cycle is completed when phlebotomines ingest amastigote-containing phagocytes, which differentiate into procyclic promastigotes and later into metacyclic promastigotes in the insect's intestinal tract7.
Dendritic cells, professional antigen-presenting cells found in tissues and lymph nodes, act as a sentinel for the immune system8. These cells are found in peripheral tissues at immature stages, mainly involved in antigen capture and processing. After contact with pathogens, DCs undergo a maturation process that culminates in their migration to the lymph nodes, subsequently presenting antigens to naïve CD4+ T cells. These cells are also essential in orchestrating the innate and adaptative immune responses that generate tolerance or inflammation9. The DC maturation process involves several aspects, including increased expression of MHC and costimulatory molecules, such as CD40 and CD86, as well as enhanced cytokine secretion. DCs express different markers, including CD11b and CD11c, and, in humans, the DCs that originate from CD14+ monocytes (moDCs) express CD1a10. CCR7 is highly expressed on DCs and indicates the complex migratory process of these cells12. CD209 and CD80 also play an important role in the initial contact with DCs and lymphocytes13.
In leishmaniasis, studies suggest that moDCs phagocytose parasites and deliver them to the draining lymph nodes (dLNs), where they present antigens to T cells13. The parasite capture mechanism is associated with cytoskeletal reorganization by actin filaments during phagocytosis, which promotes the internalization of the parasite14. Most studies concerning the roles exercised by DCs in leishmaniasis have focused on L. major, L. amazonensis, and L. braziliensis15. Interestingly, in vivo studies of Leishmania infection have demonstrated that the impairment of DC function occurs in a parasite strain-specific manner.
It has been demonstrated that during the early stages of L. amazonensis infection, DCs exhibit a decreased ability to constrain parasite infection. Conversely, in an experimental model of L. braziliensis infection, DCs were shown to mount appropriate immune responses that restricted Leishmania survival16. The chief aspects known to be associated with differential responses to Leishmania spp. infection are the degree of DC maturation and activation. This paper describes a method to investigate the role human DCs play in Leishmania infection to further understand how these cells influence disease outcomes.
NOTE: Cells were obtained from healthy donor volunteers. The procedure described herein was approved by the National Ethics Committee (number 2.751.345)-Fiocruz, Bahia, Brazil).
1. Differentiation of human dendritic cells
2. Leishmania culture
NOTE: L. amazonensis (MHOM/BR88/Ba-125) parasites were used in this assay.
3. Leishmania infection
4. Immunostaining for flow cytometry analysis
5. Actin immunostaining
6. Immunolabeling
NOTE: Perform the following steps under agitation.
7. Confocal microscopy acquisition and Fiji quantification
8. Statistical analysis
This report investigates the role of DCs in Leishmania infection using flow cytometry and confocal microscopy. Initially, the phenotypic profile of the human monocyte-derived DC was established. Notably, the obtained CD11c+ dendritic cell populations were positive for CCR7, CD209, CD80, CD1a, and HLA-DR. The results indicate that the expression of these markers in DC populations is profoundly impacted by Leishmania infection. Infected DCs exhibited augmented CD80, CD209, CCR7, and HLA-DR expression. However, downregulation of CD1a was also observed in L .amazonensis-infected DCs. Additionally, principal component analysis revealed substantial differences in the expression of these molecules (Figure 1B–D). The T-Distributed Stochastic Neighbor Embedding (t (tSNE) algorithm, a dimensionality reduction technique, was employed to better visualize how Leishmania infection affects the expression of maturation-related molecules.
Of note, the tSNE density plots show that infected DCs present differential HLA-DR and CD80 expression, which further suggests the upregulation of molecules involved in antigen presentation (Figure 2). To visualize DCs, F-actin immunostaining was performed by labeling the cells with fluorescent phalloidin. To observe L. amazonensis infection inside DCs, nuclear staining (DAPI) was used to compare Leishmania-infected cells with non-infected cells (Figure 3). The kinetic analysis of hDC infection involving L. amazonensis promastigotes (10:1) indicates the percentage of infected cells and the number of parasites per infected cell at 4 h after infection. Cells were then washed and re-incubated for 6, 12, or 24h. On average, 4-5 parasites were observed per DC in ~55% of the infected cells.
Figure 1: Marker-based human DC characterization after Leishmania amazonensis infection; gating strategy for selection of CD11c+. (A) Assessment of costimulatory molecule MFI. (B) Heatmap and (C) principal component analysis of costimulatory molecule MFI values. (D) Representative histograms and scatter plots depicting MFI for each molecule. Abbreviations: DC = dendritic cell; MFI = median fluorescence intensity; SSC-A = side scatter area; FSC-A = forward scatter area; FSC-H = forward scatter height. Please click here to view a larger version of this figure.
Figure 2: Leishmania-induced DC surface molecular expression. In-depth characterization of DC maturation landscape induced by Leishmania infection. Briefly, monocyte-derived DCs were obtained after 7 days of differentiation with GM-CSF and IL-4. Fully differentiated DCs were infected with L. amazonensis and then stained with a panel of maturation FACS antibodies. TSNE, a dimensionality reduction technique, was employed to perform a high dimensional analysis of flow cytometry data. Abbreviations: DC =dendritic cell; GM-CSF = granulocyte-macrophage colony-stimulating factor; FACS = fluorescence-activated cell sorting; IL-4 = interleukin-4; TSNE = T-Distributed Stochastic Neighbor Embedding. Please click here to view a larger version of this figure.
Figure 3: hDC infection with Leishmania amazonensis. Human dendritic cells were infected with L. amazonensis (10:1) for 4 h, washed, and labeled with phalloidin. (A) Fluorescence of F-actin labeling in infected or non-infected hDCs. Green, F-actin; blue, DAPI for nuclear staining of hDCs and nuclei of Leishmania parasites; yellow arrows represent amastigotes inside the cell; white arrows represent hDCs F-actin; greyscale, DIC. (B) Percentage of infection and parasitic burden in 400 cells randomly evaluated by fluorescence microscopy (analyzed using Anova). Scale bars = 25 µm. Abbreviations: hDC = human dendritic cell; DAPI = 4',6-diamidino-2-phenylindole; DIC = differential interference contrast. Please click here to view a larger version of this figure.
MACS buffer |
EDTA 2 mM |
PBS 1x |
BSA 0.5% |
Phosphate-buffered saline (PBS) 1x |
Ammonium chloride solution: 0.134 g of NH4Cl |
Saponin 15% |
150 mg of saponin in 1 mL of 1x PBS |
1 mL of 15% saponin in 100 mL of 1x PBS |
10% Bovine serum albumin |
100 mg – 1 mL → 10% |
1 g – 100 mL → 1% |
For 10% BSA – 1 g of BSA in 10 mL of 1x PBS |
1x PBS/ 1% BSA / 0.15% Saponin: 20 mL of 1x PBS 2 mL of 10% BSA 200 µL of 15% Saponin |
1x PBS/ 3% BSA / 0.15% Saponin: 20 mL of 1x PBS ; 6 mL of 10% BSA ; 200 µL 15% Saponin |
1x PBS / 0.3% BSA / 0.15% Saponin: 20 mL PBS; 0.6 mL of 10% BSA; 200 µL of 15% Saponin |
Table 1: Compositions of solutions used in this protocol.
Leishmaniasis is a severe public health problem worldwide. The pathogenesis of this disease is quite complex, and the mechanisms favoring parasite survival in vertebrate hosts remain elusive17. DCs are professional antigen-presenting cells found throughout the body, including filtering and lymphoid organs. Following antigen capture and processing, immature DCs undergo a complex maturation process that culminates in their migration to lymph nodes, where these cells are responsible for presenting antigens to T lymphocytes18. This maturation process is characterized by increased MHC-class II molecular expression, notably CD11c, CD86, CD80, and CD1a19. In leishmaniasis, monocyte-derived DCs phagocytose parasites and deliver the cargo to dLNs, inducing antigen presentation to T cells13.
This paper describes a concise protocol that enables the investigation of the impact of Leishmania on the immunobiological functioning of DCs in an in vitro model of infection. This protocol encompasses the use of state-of-the-art immunological techniques, including the obtaining and differentiation of human monocytes into DCs, as well as DC characterization via flow cytometry and confocal microscopy14. Initially, monocytes were purified from the PBMCs of healthy donors. The use of a positive selection method, such as anti-human CD14 microbeads, ensures a high degree of purity (>95%) of differentiated moDCs. These cells are incubated with anti-human CD14 microbeads that bind the antibody to CD14-positive cells in the sample, which are then separated by a high-gradient magnetic field inside the column of a magnetic cell separator20.
Notably, the in vitro differentiation of human monocytes into DCs requires the addition of GM-CSF and IL-4. GM-CSF is a pleiotropic growth factor that not only downregulates the expression of macrophage colony-stimulating factor (M-CSF) but also inhibits M-CSF-induced differentiation into macrophages. In addition, IL-4 acts by inhibiting macrophage colony formation, considered a suitable method for culturing moDCs in vitro21. The present protocol proposes the use of flow cytometry to assess DC differentiation by analyzing the expression of maturation-related markers, such as CCR7, CD209, CD80, CD1a, HLA-DR, and CD11c. Additionally, high-dimensional flow cytometry techniques (e.g., t-SNE) are used to precisely identify expression patterns influenced by Leishmania infection22. It is crucial to optimize the antibody dilution during immunostaining.
Confocal microscopy constitutes an excellent tool to analyze and quantify fluorescence intensity in human cells23. It is important to note that this assay requires careful manipulation before the image acquisition such as washing the coverslips gently and avoiding exposure to light. The main limitation of this method is the acquisition of suitable image resolution in confocal microscopy, which requires experience with microscopy manipulation. However, this method can be used to study the response of DCs to infection by different pathogens. Alternatively, the steps described in this protocol can also be extrapolated to other models of pathogen infection.
The authors have nothing to disclose.
We thank the Gonçalo Moniz Institute (IGM-Fiocruz) (Bahia, Brazil) and the department of microscopy for assistance. The authors are grateful to Andris K. Walter for critical analysis, English language revision, and manuscript copyediting assistance.
anti CCR7 | Thermo | ||
anti CD209 | Isofarma | ||
anti CD83 | Leica SP8 | ||
anti HLA-DR | Gibco | ||
Bovine serum albumin | Thermo | A2153-100G | Sigma |
Ciprofloxacin | Gibco | ||
confocal microscope | Thermo Fisher Scientific | ||
Fetal bovine serum | Gibco | ||
Flow Jo | Thermo Fisher Scientific | ||
Gentamicin | Thermo Fisher Scientific | ||
Glutamin | Gibco | ||
HEPES | Thermo Fisher Scientific | ||
phalloidin | Thermo Fisher Scientific | ||
Phosphate buffer solution | Peprotech | ||
prolong gold antifade kit | BD pharmigen | ||
RPMI | BD pharmigen | ||
Saponin | BD pharmigen | 47036 – 50G – F | Sigma |
Schneider's insect medium | software BD biosciences |
.